window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical studies

  • Clinical Development,Clinical studies,Hematology,Regulatory Affairs,Research & Development

    MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD

    MaaT Pharma has published retrospective real-world data from its CHRONOS [...]

    April 10, 2026
  • Clinical studies,Gastroenterology,Healthcare leadership,Liver disease,Metabolic Diseases

    European liver experts highlight rising MASLD burden at EASL symposium in Budapest

    European liver disease specialists have highlighted the growing burden of [...]

    April 10, 2026
  • Artificial Intelligence,Clinical studies,Drug discovery,Neurosciences,Pharmaceuticals and therapeutics

    AI-derived drug candidate reduces fentanyl intake in preclinical opioid study

    A study published in Proceedings of the National Academy of [...]

    April 8, 2026
  • Cardiovascular diseases,Clinical studies,Metabolic Diseases

    Liver disease linked to higher heart failure risk in AFib patients

    Liver-metabolic disease is linked to increased heart failure risk in [...]

    March 23, 2026
  • Clinical studies,Dermatology,Medical devices

    Laser therapy reduces bacterial load in burn wounds, study shows

    A single photobiomodulation session reduced bacterial load in acute burn [...]

    March 3, 2026
  • Clinical studies,Digital Health,Global health,Mental health,Neurosciences

    Young adults in US, UK and Australia hit hardest by global mental health decline

    Young adults in wealthy countries are four times more likely [...]

    February 25, 2026
  • Clinical studies,Digital Health,Drug Delivery & Formulation,Neurosciences

    Study confirms Nerivio REN wearable safe with continuous glucose monitoring devices

    A new study confirms that Theranica’s Nerivio REN wearable for [...]

    February 25, 2026
  • Biologics & Biosimilars,Clinical studies,Dermatology,Pharmaceuticals and therapeutics

    Almirall meets guidance with 12.4% net sales growth and dermatology portfolio progress in 2025

    Almirall delivered net sales growth of 12.4% in 2025, surpassing [...]

    February 23, 2026
  • Biologics & Biosimilars,Clinical studies,Clinical Trials,Pharmaceuticals and therapeutics

    Abivax shows anti-fibrotic activity for obefazimod in IBD at ECCO 2026

    Abivax has presented new preclinical and clinical data for obefazimod [...]

    February 23, 2026
  • Chronic diseases,Clinical Development,Clinical studies,Drug Development,Drug discovery,Gastroenterology,Immunology,Pharmaceuticals and therapeutics

    Patients with Crohn’s disease maintain steroid-free remission for three years with Lilly’s Omvoh (mirikizumab)

    Long-term VIVID-2 data show more than 90% of patients with [...]

    February 19, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
  • START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth
    Categories: Clinical Development, Clinical Trials, Healthcare leadership, Oncology
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top